BIOMAT Database Logo BIOMAT Database Logo

Rituximab as a treatment option for refractory endogenous anterior uveitis. 2007

C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Department of Ophthalmology, St. Franziskus Hospital, Muenster, Germany.

BACKGROUND To report on anti-CD20 antibody therapy in a patient with uveitis refractive to immunosuppression therapy. METHODS Case report with ophthalmoscopic, optical coherence tomography and fluorescein-angiographic findings. RESULTS A 49-year-old woman was suffering from bilateral, noninfectious chronic anterior uveitis refractive to corticosteroids and immunosuppressive drugs. Bilateral visual acuity was 20/100 due to cataract and cystoid macular edema (CME). After treatment with rituximab, vision and CME improved, and uveitis was stable until the final visit (follow-up at 12 months). CONCLUSIONS The case report suggests that rituximab may be helpful for selected patients with chronic anterior uveitis refractive to corticosteroids and immunosuppressive medication.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009887 Ophthalmoscopy Examination of the interior of the eye with an ophthalmoscope. Ophthalmoscopies
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005451 Fluorescein Angiography Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature. Fluorescence Angiography,Fundus Fluorescence Photography,Angiography, Fluorescein,Angiography, Fluorescence,Fluorescence Photography, Fundus,Photography, Fundus Fluorescence
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005654 Fundus Oculi The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed) Fundus of the Eye,Ocular Fundus,Fundus, Ocular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Adenotonsillectomy as a treatment option for poststreptococcal uveitis.
April 2002, The Laryngoscope,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
December 2016, The Journal of rheumatology,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
[Refractory anterior uveitis].
February 2011, Journal francais d'ophtalmologie,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Neisseria meningitidis endogenous endophthalmitis presenting as anterior uveitis.
January 2007, Journal of pediatric ophthalmology and strabismus,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Janus Kinase Inhibitors as a Third-Line Therapy for Refractory Endogenous Noninfectious Uveitis.
May 2024, Ocular immunology and inflammation,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma?
January 2020, Acta gastro-enterologica Belgica,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Rituximab as treatment for refractory kidney transplant rejection.
June 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome.
June 2020, Journal of neuroimmunology,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
[Corticotherapy in endogenous anterior uveitis].
January 1976, Revista de chirurgie, oncologie, radiologie, o. r. l., oftalmologie, stomatologie. Seria: Oftalmologie,
C Tappeiner, and C Heinz, and C Specker, and A Heiligenhaus
Omalizumab as a treatment option for antihistamine-refractory aquagenic urticaria.
July 2022, BMJ case reports,
Copied contents to your clipboard!